Follicular Lymphoma

Showing NaN - NaN of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Untreated FolliculaR Lymphoma Treated With OBinituzumAb

Active, not recruiting
  • Follicular Lymphoma
  • Pescara, Abruzzo, Italy
  • +45 more
Nov 21, 2022

Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)

Active, not recruiting
  • Follicular Lymphoma
  • tisagenlecleucel
  • Duarte, California
  • +29 more
Nov 2, 2022

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Follicular Lymphoma
  • Little Rock, Arkansas
  • +95 more
Sep 9, 2022

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)

Recruiting
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • EO2463
  • +2 more
  • Boston, Massachusetts
  • +9 more
Jul 26, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Follicular Lymphoma Trial in Worldwide (ibrutinib, to match ibrutinib, rituximab)

Active, not recruiting
  • Follicular Lymphoma
  • Mobile, Alabama
  • +168 more
Oct 6, 2021

Follicular Lymphoma Trial in Worldwide (Rituximab, Lenalidomide, Rituximab - CHOP)

Active, not recruiting
  • Follicular Lymphoma
  • Concord, New South Wales, Australia
  • +34 more
Jul 23, 2021

Follicular Lymphoma Trial in Worldwide (Duvelisib, Placebo, Rituximab)

Terminated
  • Follicular Lymphoma
  • Frankston, Victoria, Australia
  • +4 more
Mar 15, 2021

Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)

Completed
  • Follicular Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Los Angeles, California
  • +40 more
Feb 20, 2020

Follicular Lymphoma Trial in Worldwide (Venetoclax, Bendamustine, Rituximab)

Completed
  • Follicular Lymphoma
  • Mobile, Alabama
  • +70 more
Jun 3, 2019

Follicular Lymphoma Trial in Italy (Rituximab, Mitoxantrone, Bendamustine)

Completed
  • Follicular Lymphoma
  • Rituximab, Mitoxantrone, Bendamustine
  • Meldola, Forlì-Cesena, Italy
  • +36 more
Feb 29, 2016

Follicular Lymphoma Trial in Worldwide (fludarabine, rituximab, VELCADE)

Terminated
  • Follicular Lymphoma
  • Amiens, 80, France
  • +42 more
Dec 10, 2012

Non Hodgkin Lymphoma, Follicular Lymphoma Trial in Italy (LR-CHOP21)

Unknown status
  • Non Hodgkin Lymphoma
  • Follicular Lymphoma
  • Alessandria, Italy
  • +17 more
Oct 12, 2011

Follicular Lymphoma Trial in Italy (R-CVP, R-CHOP, R-FM)

Unknown status
  • Follicular Lymphoma
  • Acquaviva delle fonti (BA), Italy
  • +81 more
Feb 14, 2011

Follicular Lymphoma Trial in Bologna (FM+R, Zevalin (Ibritumomab Tiuxetan))

Completed
  • Follicular Lymphoma
  • FM+R
  • Zevalin (Ibritumomab Tiuxetan)
  • Bologna, BO, Italy
    Istituto di Ematologia e Oncologia Medica SerĂ gnoli
Mar 10, 2009